Skip to main content
. 2019 Oct-Dec;11(4):373–381. doi: 10.4103/JLP.JLP_42_19

Table 3.

Symptoms reported by the study subjects at the time of sample collection

Symptoms Population (n=152), n (%) Asthmatic (n=119), n (%) Control (n=33), n (%) P OR 95% CI
Cough 142 (93.3) 112 (94.1) 30 (91) 0.030 1.56 1.04-2.33
Wheezing 119 (78.2) 102 (85.7) 17 (51.5) <0.001 5.29 2.23-12.56
Sputum production 113 (74.3) 92 (77.3) 21 (63.6) 0.121 1.83 0.85-3.93
Dyspnea 97 (63.5) 78 (65.5) 19 (57.6) 0.963 1.03 0.34-3.09
Chest tightness 66 (43.4) 55 (46.2) 11 (33.3) 0.344 1.57 0.62-4.01
Chest pain 57 (37.6) 48 (40.3) 9 (27.3) 0.255 1.73 0.67-4.47
Lethargy 48 (31.5) 41 (34.5) 7 (21.2) 0.232 2.05 0.63-6.65
Hemoptysis 5 (3.3) 3 (2.5) 2 (6.1) 0.499 0.59 0.13-2.71
Night distress 60 (39.5) 53 (44.5) 7 (21.2) 0.031 3.29 1.12-9.72
Morning distress 37 (24.4) 33 (27.7) 4 (12.1) 0.079 2.98 0.88-10.05
Fever 45 (29.6) 38 (32) 7 (21.2) 0.585 1.27 0.54-3.03
Weight loss 18 (12) 9 (7.6) 9 (27.3) 0.001 0.13 0.04-0.44
Vertigo 8 (5.3) 5 (4.2) 3 (9.1) 0.277 0.44 0.1-1.93

OR=Odds ratio, CI=Confidence interval